Infrared illumination for difficult peripheral venous catheterisation in critically ill adult patients: the prospective, randomised, multicentre ICARE trial

医学 重症监护医学 随机对照试验 外科 急诊医学
作者
R. Ouedraogo,Aline da Silva Alves,Amélie Bruant,Oumar Sy,Cécilia Tabra Osorio,Frédérique Schortgen,Amélie Chenal,Damien Contou,Laurence Krzyzaniak,Muriel Fartoukh,Marianne Le Joncour,Nicolas Mongardon,L. Benaïssa,Daniel Da Silva,Meriem Bouguerra,Sophie Demeret,Stéphanie Dubois,Eric Starczala,Chirine Petyt,Matthieu Schmidt,Séverine Dezellus,Jean Francois Georger,Ann-Cécile Pallud,Damien Carras,Fabien Boussely,Étienne Audureau,Armand Mekontso Dessap
出处
期刊:BMJ Open [BMJ]
卷期号:15 (2): e090611-e090611
标识
DOI:10.1136/bmjopen-2024-090611
摘要

Introduction The insertion of a peripheral venous line is of paramount importance in the stabilisation of critically ill patients. It is a preferred method of venous access over more invasive techniques due to its immediacy and fewer complications. Difficulties of catheterisation can result in delays to treatment, increased complication risks and pain, and a waste of valuable time and healthcare resources. Our hypothesis is that infrared vein illumination could improve the success rate of peripheral venous catheterisation in critically ill patients at risk of difficult catheterisation. Methods and analysis This is a prospective, multicentre, randomised, open-label controlled trial. It will be conducted in France and will involve critically ill patients at risk of difficult peripheral catheterisation. Patients will be randomly assigned to usual care or infrared vein illumination. The primary outcome is the rate of successful peripheral venous catheterisation at first puncture. Secondary outcomes include time to placement, overall rate of successful peripheral venous catheterisation, number of punctures, quality (calibre of the catheter), replacement rate, need for central line and local complications (dysfunction, diffusion, haematoma and lymphangitis). Ethics and dissemination The study has been granted ethical approval (CPP Ile de France 1). Following the provision of informed consent, patients will be included in the study. The results will be submitted for publication in peer-reviewed journals. Trial registration number NCT03932214 .

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer应助lzb采纳,获得10
1秒前
zy990125发布了新的文献求助50
1秒前
1秒前
wssy发布了新的文献求助10
2秒前
科研通AI6.3应助顾泽采纳,获得10
2秒前
11完成签到 ,获得积分10
3秒前
yang完成签到 ,获得积分0
3秒前
雷霆康康完成签到,获得积分0
3秒前
桐桐应助小聖采纳,获得10
3秒前
生动枫完成签到,获得积分10
4秒前
yuhan完成签到,获得积分20
5秒前
6秒前
whuhustwit发布了新的文献求助10
8秒前
9秒前
冷酷中蓝关注了科研通微信公众号
10秒前
11秒前
山野的雾完成签到 ,获得积分10
11秒前
Orange应助负责芒果采纳,获得10
13秒前
13秒前
13秒前
水123发布了新的文献求助10
13秒前
Lbc完成签到,获得积分20
13秒前
14秒前
lijunhao完成签到,获得积分10
14秒前
16秒前
17秒前
大个应助sss采纳,获得10
17秒前
游隼儿完成签到,获得积分10
17秒前
小聖发布了新的文献求助10
17秒前
养不活的细胞完成签到,获得积分10
18秒前
Jessy畅畅应助隐形的惜萱采纳,获得10
19秒前
yyy应助JC325T采纳,获得20
19秒前
小小发布了新的文献求助10
21秒前
FashionBoy应助香槟问题采纳,获得10
21秒前
冷酷中蓝发布了新的文献求助10
22秒前
神勇的铁身完成签到,获得积分20
22秒前
科研小渣渣完成签到,获得积分10
23秒前
23秒前
23秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Periodic Report Summary 2 - AFTER (A Framework for electrical power sysTems vulnerability identification, dEfense and Restoration) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7319318
求助须知:如何正确求助?哪些是违规求助? 8935021
关于积分的说明 18940685
捐赠科研通 6978073
什么是DOI,文献DOI怎么找? 3214386
关于科研通互助平台的介绍 2382259
邀请新用户注册赠送积分活动 2193366